Soleno Therapeutics
SLNO
SLNO
165 hedge funds and large institutions have $2.29B invested in Soleno Therapeutics in 2024 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 78 increasing their positions, 25 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
4% less capital invested
Capital invested by funds: $2.38B → $2.29B (-$85M)
2.86% less ownership
Funds ownership: 121.22% → 118.37% (-2.9%)
11% less funds holding in top 10
Funds holding in top 10: 9 → 8 (-1)
Holders
165
Holding in Top 10
8
Calls
$120M
Puts
$123M
Top Buyers
| 1 | +$49.7M | |
| 2 | +$42.7M | |
| 3 | +$29.6M | |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
+$17.3M |
| 5 |
Holocene Advisors
New York
|
+$16.2M |
Top Sellers
| 1 | -$121M | |
| 2 | -$76.6M | |
| 3 | -$24.8M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$24.6M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$14.5M |